Investors / United States / Tachyon Ventures
Tachyon Ventures
Venture capital · Los Angeles, CA, United States · North America
Tachyon Ventures is a specialist biotech investment firm that backs early-stage biotech companies and acquires limited partner interests in biotech venture funds. It runs direct venture strategies in the United States and Europe alongside a secondaries strategy focused on late-stage biotech fund interests.
Invests inHealthcare & Biotech
In its own wordsbiotechtherapeuticslife sciencesacademic spinoutssecondariesbioengineering
Your fit with Tachyon Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTachyon Ventures lists 15 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, Springboard and California Innovation Fund.
Counts come from funding rounds that name Tachyon Ventures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Tachyon Ventures' whole history. Rounds on record name 1 company; its own site lists 15. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 39th | 15 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 69th | 7% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 4 |
| Springboard | 4 |
| California Innovation Fund | 2 |
| Mission BioCapital | 2 |
| Pathway Bioventures | 2 |
| Plum Alley Ventures | 2 |
| 8VC | 1 |
| AAF Management | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1493%
- No longer answers00%
- Points to another company17%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Tachyon Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Tachyon Ventures| Date | Company | Stage |
|---|---|---|
| 13 May 2025 | Series A |
Round details for Tachyon Ventures
Amounts, full round histories and every co-investor in Tachyon Ventures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
15 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Absci creates biologics with AI technology | Healthcare & Biotech | Portfolio page | ||
| The company designs and develops a new class of miniprotein medicines using artificial intelligence and lab validation. | Healthcare & Biotech | Portfolio page | ||
| Altay Therapeutics develops small molecules to address serious diseases by inhibiting transcription factors | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| EnClear Therapies develops treatments for central nervous system diseases using precision dosing and a proprietary platform | Healthcare & Biotech | Portfolio page | ||
| EpiBone grows personalized bone and cartilage products using stem cells for repair and healing | Healthcare & Biotech | Portfolio page | ||
| Haima Therapeutics develops a platelet-inspired platform technology to address uncontrolled bleeding | Healthcare & Biotech | Portfolio page | ||
| Mammoth Biosciences develops in vivo gene editing therapeutics and diagnostics using CRISPR technology | Healthcare & Biotech | Portfolio page | ||
| Mirecule develops RNA therapies for cancer and muscular dystrophy | Healthcare & Biotech | Portfolio page | ||
| Palm Therapeutics develops therapeutics targeting protein palmitoylation | Healthcare & Biotech | Portfolio page | ||
| Peptilogics is a surgical therapeutics company that develops a novel anti-biofilm drug to cure and prevent medical device-related infections. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Scipher Medicine is a precision immunology company that matches patients with their most effective therapy using AI and molecular data | Healthcare & Biotech | Portfolio page | ||
| Stylus Medicine is developing in vivo genetic medicines to unlock cures. | Healthcare & Biotech | May 2025Series A | Page + round | |
Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- tachyon.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 13 May 2025
- Companies checked
- 15
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Tachyon Ventures' profile as data
Pull Tachyon Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/tachyon.vc
# also
GET /v1/firms/tachyon.vc/portfolio
GET /v1/firms/tachyon.vc/coinvestors
GET /v1/firms/tachyon.vc/news